Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Nephrologist Allan Kavalich, MD, to Discuss Improvements in Infections Associated With Peritoneal Dialysis Catheters With Use of NeutroPhase - Pure 0.01% Hypochlorous Acid Solution EMERYVILLE,...
-
SOUTH SAN FRANCISCO, Calif., Feb. 6, 2014 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX) announced today the pricing of an underwritten public offering of 3,000,000 shares of its...
-
PLEASANTON, Calif., Feb. 6, 2014 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) today announced it will release first quarter 2014 financial results on Thursday, March 6, 2014, at 4:00 PM...
-
BUFFALO, N.Y., Feb. 6, 2014 (GLOBE NEWSWIRE) -- Medical Acoustics, LLC is pleased to announce the appointment of Sensormedics Italia as master distributor for Europe for the Lung Flute, a breakthrough...
-
PITTSBURGH, PA., Feb. 6, 2014 (GLOBE NEWSWIRE) -- Last week, U Squared Interactive, a joint venture between UPMC Insurance Services and Ultrasis PLC, officially introduced the Beating the Blues US...
-
WASHINGTON, Feb. 6, 2014 (GLOBE NEWSWIRE) -- March is Colorectal Cancer Awareness Month, a time when thousands of individuals, companies and community groups take to the streets to help raise...
-
WASHINGTON, Feb. 6, 2014 (GLOBE NEWSWIRE) -- March is National Colon Cancer Awareness Month, a time when thousands of individuals, companies and community groups take to the streets to help raise...
-
PHILADELPHIA, PA., Feb. 6, 2014 (GLOBE NEWSWIRE) -- Independence Blue Cross (IBC) today announced that Paul A. Tufano will become chief executive officer of AmeriHealth Caritas, assuming overall...
-
SHELBURNE, Vt., Feb. 6, 2014 (GLOBE NEWSWIRE) -- When Christina Guerin was a child, she decided she didn't want a career in radio soap operas. As a young girl, she spent many days and nights in a...
-
MORAGA, Calif., Feb. 6, 2014 (GLOBE NEWSWIRE) -- Trigemina, Inc., a biopharmaceutical company focused on the discovery and development of non-narcotic, nasally delivered, analgesic drug products,...